Opportunistic salpingectomy, or the removal of fallopian tubes in women already undergoing another abdominal or gynecological ...

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that adult patients ...

The marathon session, conducted on January 1 from 8 am to 5 pm, was led by Prof Santosh Kumar, head of the urology team.

Led by Prof Santosh Kumar, the urology team at Chandigarh’s PGIMER completes a marathon session of four robotic radical ...

A woman's decades-long struggle with incontinence was finally solved when doctors discovered a rare condition.

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

It has been a year since a major surgery changed Randy Moss' life on Friday. After a long break from Instagram, Moss made a ...